05239nam 2200793z- 450 991089990000332120240131152553.00-323-47785-2(CKB)4100000005464037(OCoLC)1050449004(EXLCZ)99410000000546403720180812h20182019 fy- 0engtxtrdacontentstirdacontentcrdamediacrrdacarrierConsultative Hemostasis and Thrombosis /Editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle, David A. GarciaFourth ed.Philadelphia, PA :Elsevier,2018,©20191 online resource (xvi, 869 pages color illustrationsClinicalKeyRevised edition of: Consultative hemostasis and thrombosis / Editors, Craig S. Kitchens, Craig M. Kessler, Barbara A. Konkle. 3rd ed. ©2013.0-323-46202-2 Includes bibliographical referencesPart 1: Hemorrhagic processes. Consultative process -- An approach to the bleeding patient: correlation of clinical symptoms and signs with laboratory testing -- Hemophilia A and B -- Less common congenital disorders of hemostasis -- Acquired coagulation disorders due to inhibitors -- von Willebrand disease -- General aspects of thrombocytopenia, platelet transfusions, and thrombopoietic growth factors -- Primary immune thrombocytopenia -- Congenital and acquired disorders of platelet function and number -- Purpura and other hematovascular disorders -- HHT -- Disseminated intravascular coagulation -- The cross-talk of inflammation and coagulation in infectious disease and their roles in disseminated intravascular coagulation -- Part 2: Thrombotic processes. Thrombophilia: clinical and laboratory assessment and management -- Pediatric aspects of thrombophilia -- Deep vein thrombosis, pulmonary embolism and primary pulmonary hypertension -- Venous thromboses at unusual sites -- The post thrombotic syndrome -- Thrombocytosis: essential thrombocytemia and reactive causes -- Antiphospholipid syndrome -- Antiplatelet treatment in cardiovascular medicine -- Non-arteriosclerotic arterial occlusive disease -- Thrombosis and cancer -- Thrombotic thrombocytopenic purpura -- Hemostatic disorders of complement activation (PNH and aHUS) -- Heparin-induced thrombocytopenia -- Part 3: Therapeutic agents. Antithrombotic agents -- Blood component and pharmacological agents -- Therapeutic apheresis: applications for hemorrhagic & thrombotic disorders -- Vena caval filters -- Part 4: Issues specific to women. Thrombotic risk of contraceptives and other hormonal therapies -- Bleeding and the management of hemorrhagic disorders in pregnancy -- Thrombophilia in pregnancy -- Part 5: Special issues. Surgery and hemostasis -- Anticoagulation in the perioperative period -- Understanding and managing the coagulopathy of liver disease -- Outpatient anticoagulant therapy -- Hematologic interventions for acute central nervous system disease -- Pending: atrial septal abnormalities and cryptogenic stroke -- Hemorrhage control and thrombosis following severe injury -- Hemostatic aspects of sickle cell disease"With authoritative coverage of rare and common hemostatic disorders, Consultative Hemostasis and Thrombosis, 4th Edition, keeps you both up to date with all that's new in this fast-moving field as well as reviewing background and development and citing pertinent classical literature. Broad differential diagnoses are provided, underscoring the editors' position that correct treatment begins with correct diagnosis"--Publisher's description.ClinicalKey.Blood coagulation disordersAnticoagulants (Medicine)Blood platelet disordersFibrinolytic agentsHemostasisPhysiological aspectsThrombosisPathophysiologyBlood Coagulation DisordersThrombosispathologyBlood Platelet DisordersHemostasisphysiologyFibrinolytic Agentstherapeutic useAnticoagulantstherapeutic useBlood coagulation disorders.Anticoagulants (Medicine)Blood platelet disorders.Fibrinolytic agents.HemostasisPhysiological aspects.ThrombosisPathophysiology.Blood Coagulation Disorders.Thrombosispathology.Blood Platelet Disorders.Hemostasisphysiology.Fibrinolytic Agentstherapeutic use.Anticoagulantstherapeutic use.Kitchens Craig S.Kessler Craig M.Konkle Barbara A.Garcia David A(David Allen),MMUMMUMMUOCLCOINMNLEOPELSUABOPELSBOOK9910899900003321Consultative Hemostasis and Thrombosis4214008UNINA